Ultragenyx Pharmaceutical Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2018
Total Assets: $719.6M
Liabilities Breakdown FY2018
Total Liabilities: $110.7M
Asset Breakdown
Total Assets: $719.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $113.4M | 15.8% |
| Accounts Receivable | $12.7M | 1.8% |
| Inventory | $7.1M | 1.0% |
| Property, Plant & Equipment | $20.0M | 2.8% |
| Goodwill | $44.4M | 6.2% |
| Intangible Assets | $129.2M | 18.0% |
| Other Assets | $392.6M | 54.6% |
Liabilities Breakdown
Total Liabilities: $110.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $12.3M | 11.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $98.4M | 88.9% |